01652 福森藥業
公司資料 - 財務狀況表
福森藥業有限公司 股票編號: 01652
FUSEN PHARMACEUTICAL COMPANY LIMITED 集團網址: http://www.fusenyy.com
非流動資產
2024/12 - 末期
人民幣(¥)
與去年末期
比較
2023/12
人民幣(¥)
2022/12
人民幣(¥)
2021/12
人民幣(¥)
2020/12
人民幣(¥)
投資物業14,280,000-7.200%15,388,00016,497,00017,605,00018,713,000
物業、廠房、設備及其他383,655,0009.533%350,264,000312,108,000281,877,000238,002,000
租賃土地237,675,0001.248%234,745,000217,637,000224,157,000247,926,000
無形資產28,135,00024.762%22,551,000483,000683,000883,000
聯營公司及共同控制公司權益34,601,000-74.920%137,961,000178,309,000198,064,00067,648,000
其他非流動資產80,203,000400.206%16,034,00011,178,0007,728,0007,808,000
778,549,0000.207%776,943,000736,212,000730,114,000580,980,000
存貨137,082,000-15.234%161,718,000110,649,000121,845,000105,415,000
 
流動資產
現金及銀行結存21,056,000-39.579%34,849,000128,106,00081,063,000297,038,000
其他流動資產301,474,000-18.572%370,235,000375,301,000306,314,000257,914,000
持作出售資產0--0000
459,612,000-18.911%566,802,000614,056,000509,222,000660,367,000
 
流動負債
其他流動負債772,445,00016.241%664,520,000722,082,000489,266,000547,606,000
持作出售資產相關負債0--0000
772,445,00016.241%664,520,000722,082,000489,266,000547,606,000
流動資產淨值(312,833,000)220.139%(97,718,000)(108,026,000)19,956,000112,761,000
資產總額減流動負債465,716,000-31.434%679,225,000628,186,000750,070,000693,741,000
 
非流動負債
97,354,000-16.791%116,999,00015,293,00093,126,00035,492,000
 
資本及儲備
   股本6,179,000-2.076%6,310,0006,383,0006,479,0006,513,000
   儲備363,492,000-34.765%557,208,000607,784,000651,690,000652,929,000
   其他0--0000
股東資金369,671,000-34.399%563,518,000614,167,000658,169,000659,442,000
非控股權益(1,309,000)1.316%(1,292,000)(1,274,000)(1,225,000)(1,193,000)
其他0--0000
368,362,000-34.482%562,226,000612,893,000656,944,000658,249,000
 
承擔及或然負債
承擔----82,205,00017,634,0001,819,000103,617,000
或然負債----0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.